Risk analysis of enfortumab vedotin: A real-world approach based on the FAERS database
While most findings aligned with the existing data, new signs such as lichenoid keratosis and small intestinal perforation were identified. Further studies are necessary to validate these findings and emphasize the need for the clinical monitoring of EV-related ADEs.
Authors
- Fu‐Chun Zheng (ORCID: https://orcid.org/0000-0003-3184-3054)
- Songhui Xu (ORCID: https://orcid.org/0000-0003-0269-9129)
- Situ Xiong (ORCID: https://orcid.org/0000-0003-3641-1381)
- Xiaoqiang Liu (ORCID: https://orcid.org/0000-0002-5302-7552)
- Sheng Li (ORCID: https://orcid.org/0000-0003-1205-8632)
- Liu Wei (ORCID: https://orcid.org/0009-0007-9244-4117)
- Bin Fu (ORCID: https://orcid.org/0000-0003-0547-3061)
- Zhipeng Wang (ORCID: https://orcid.org/0009-0004-4444-089X)
- Yifan Tan
- Jin Zeng
- Yuanzhuo Du
- Yuyang Yuan
Institutions
- Nanchang University (CN)
Publication Details
- Journal
- Heliyon
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e37544
- Citations
- 2
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.90